CCND1 and irritable bowel syndrome: Here, we have also shown that the therapeutic application of IBS and MBS in mice with BCL1 leukemia induced marked antitumor action as evaluated by a reduced number of BCL1 cells counted in peripheral blood (Figure 6a) and spleen (Figure 6b).